Session 3 – Accelerating Biomedical Innovations
Date: 22 July (Wednesday) 12:20 – 13:50 (GMT+8)
Venue: 701EF, 7F, TaiNEX2 / Online event platform
Robert is Managing Director of healthcare investments at CDIB Capital Group. Prior to joining CDIB, he was Principal, Venture Investments at Johnson & Johnson Development Corporation (JJDC), responsible for the venture and private equity investments in life science and healthcare in Asia Pacific region. Prior to JJDC, Robert served as Director of Business Development & Strategy of Greater China at GlaxoSmithKline, and worked in the Global Corporate Development team of Charles River Laboratories in Boston USA. Robert has executed over $3 billion M&A and investment transactions in the US, Europe and Asia.
Robert holds a PhD in Pharmacology from University of Rochester, an MBA from the University of Chicago Booth School of Business and a Master Degree in Medicine (7-year program) from Tongji Medical University. Robert also received the residency training in Urology at Union Hospital, Wuhan China.